Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status

Einat Fireman Klein1 Pulmonary Division, Carmel Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel, [email protected]Correspondence[email protected]

Yochai Adir1 Pulmonary Division, Carmel Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel, [email protected]

Amir Krencel2 Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

Regina Peri2 Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

Bella Vasserman2 Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

Elizabeth Fireman3 Institute of Pulmonary Diseases, National Laboratory Service for Interstitial Lung Diseases, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel;4 Department of Occupational and Environmental Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Aharon Kessel2 Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

show all

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date